![Patrick Fabbio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 287 955 $ al 30/06/2026
Patrick Fabbio currently works at BeyondSpring, Inc., as Independent Director from 2018 and Protara Therapeutics, Inc., as Chief Financial Officer from 2023.
Mr. Fabbio also formerly worked at NPS Pharmaceuticals, Inc., as Vice President-Finance from 2012 to 2015, Biomatrix, Inc., as Controller, Progenics Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Senior VP, Ikano Therapeutics, Inc., as Chief Financial Officer from 2009 to 2011, Coopers & Lybrand (London), as Auditor, Catalent Pharma Solutions, Inc., as Vice President-Finance, Innovation & Growth, electroCore, Inc., as Chief Financial Officer, WindMIL Therapeutics, Inc., as Chief Financial Officer from 2020 to 2021, and Rafael Holdings, Inc., as Chief Financial & Accounting Officer in 2023.
Mr. Fabbio received his undergraduate degree from Pace University and Masters Business Admin degree from The Leonard N Stern School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/01/2026 | 64.115 ( 0,11 % ) | 244 919 $ | 30/06/2026 | |
BEYONDSPRING INC. 0,06 % | 01/04/2026 | 24.592 ( 0,06 % ) | 43 036 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BEYONDSPRING INC. | Director/Miembro de la Junta | 02/01/2018 |
| PROTARA THERAPEUTICS, INC. | Director Financiero/CFO | 30/01/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| RAFAEL HOLDINGS, INC. | Presidente | 01/01/2023 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Director Financiero/CFO | 01/09/2021 |
| PROGENICS PHARMACEUTICALS, INC. | Director Financiero/CFO | 27/03/2020 |
| NPS PHARMACEUTICALS, INC. | Director Financiero/CFO | 01/05/2015 |
Ikano Therapeutics, Inc.
 Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director Financiero/CFO | 18/01/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Biomatrix, Inc.
 Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets viscoelastic products | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Ikano Therapeutics, Inc.
Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coopers & Lybrand (London)
 Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
electroCore, Inc.
 electroCore, Inc. Medical SpecialtiesHealth Technology Develops non-invasive neuromodulation therapies | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
BeyondSpring, Inc.
 BeyondSpring, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cancer therapies | Health Technology |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
